Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US36315X1019

SecurityLKFT / Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock)
InstitutionBarometer Capital Management Inc.
Latest Disclosed Ownership38,100 shares
Latest Disclosed Value $ 1,143,000
Barometer Capital Management Inc. reports 2.70% increase in ownership of LKFT / Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock)

On May 12, 2026 - Barometer Capital Management Inc. filed a 13F-HR form disclosing ownership of 38,100 shares of Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock) (US:LKFT) valued at $1,143,000 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 37,100 shares of Lakefront Biotherapeutics NV - Depositary Receipt (Common Stock). This represents a change in shares of 2.70% during the quarter. The current value of the position is $1,048,131 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Galapagos Common 36315X101 38,100 1,000 2.70 1,143 29.45 0.3912
2026-02-12 2025-12-31 13F Fresenius Medical Care Common 36315X101 37,100 9,483 34.34 884 -7.64 0.2128
2025-11-13 2025-09-30 13F Galapagos Common 36315X101 27,617 10,700 63.25 957 102.11 0.2187
2025-08-14 2025-06-30 13F Galapagos Common 36315X101 16,917 3,400 25.15 474 39.53 0.1309
2025-05-14 2025-03-31 13F Galapagos Common 36315X101 13,517 4,100 43.54 340 45.49 0.1265
2025-02-13 2024-12-31 13F First Trust Industrials ETP 36315X101 9,417 -1,300 -12.13 233 -24.35 0.0935
2024-11-14 2024-09-30 13F Galapagos Common 36315X101 10,717 1,300 13.80 309 32.19 0.0890
2024-08-09 2024-06-30 13F Galapagos Common 36315X101 9,417 1,700 22.03 233 6.39 0.0900
2024-05-08 2024-03-31 13F Galapagos Common 36315X101 7,717 4,717 157.23 220 80.99 0.0569
2024-02-14 2023-12-31 13F Galapagos Common 36315X101 3,000 3,000 122 0.0346
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.